Inflation Reduction Act: Reforms to patient cost-sharing
The Inflation Reduction Act (IRA) of 2022 contains some of the most significant changes in healthcare regulation since the introduction of the Medicare...
Rhett Johnson has over 25 years of consulting experience, assisting life sciences clients develop commercialization strategies that generate a sustainable competitive advantage in a complex and constantly evolving healthcare marketplace. Areas of focus include corporate growth strategy, asset evaluations and product strategy, pricing and market access, analytics and forecasting, and competitive analysis.
Mr. Johnson joined CRA as an Associate after studying economics at the University of Chicago. Mr. Johnson now co-leads CRAs Global Life Sciences Strategy Consulting team, with responsibility for innovation and practice growth.